MLEC — Moolec Science SA Share Price
Last trade - 00:00- $45.85m
- $66.01m
- $5.63m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 16.4 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 5.85 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -36.68% | ||
| Return on Equity | -174.68% | ||
| Operating Margin | -116.72% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | 0.91 | 5.63 | 6.64 | 8.63 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Moolec Science SA is a science based food ingredient company. The Company focuses on the production of animal proteins within plants by using molecular farming technology. It operates globally across the United States, Europe, and South America. The Company’s product portfolio and pipeline focus on improving the agronomic efficiency of widely used crops such as soy, pea, and safflower. Its product portfolio includes GLASO, PIGGY SOOY, VALORASOY, and MYCOFOOD. The Company’s GLASO product is a genetically engineered safflower variety designed to produce higher levels of gamma linolenic acid (GLA). Its PIGGY SOOY product is a bioengineered soybean that contains pig proteins used in creating meat like textures and food ingredients. The Company also has a growing international patent portfolio of approximately 25 patents, both granted and pending, for its technology.
Directors
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- January 1st, 1970
- Public Since
- March 1st, 2023
- No. of Employees
- 52
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 10,891,761
- Address
- 89 Nexus Way, Camana Bay, GRAND CAYMAN, KY1-9009
- Web
- http://www.moolecscience.com/
- Phone
- Auditors
- Price Waterhouse & Co SRL
Latest News for MLEC
Upcoming Events for MLEC
Q1 2026 Moolec Science SA Earnings Release
Q2 2026 Moolec Science SA Earnings Release
Similar to MLEC
22nd Century
NASDAQ Capital Market
Aquabounty Technologies
NASDAQ Capital Market
Arcadia Biosciences
NASDAQ Capital Market
Australian Oilseeds Holdings
NASDAQ Capital Market
Baikang Biological group
NASDAQ Capital Market
FAQ
As of Today at 21:08 UTC, shares in Moolec Science SA are trading at $4.21. This share price information is delayed by 15 minutes.
Shares in Moolec Science SA last closed at $4.21 and the price had moved by -96.85% over the past 365 days. In terms of relative price strength the Moolec Science SA share price has underperformed the S&P500 Index by -97.36% over the past year.
The overall consensus recommendation for Moolec Science SA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreMoolec Science SA does not currently pay a dividend.
Moolec Science SA does not currently pay a dividend.
Moolec Science SA does not currently pay a dividend.
To buy shares in Moolec Science SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $4.21, shares in Moolec Science SA had a market capitalisation of $45.85m.
Here are the trading details for Moolec Science SA:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: MLEC
Based on an overall assessment of its quality, value and momentum Moolec Science SA is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Moolec Science SA is $30.00. That is 612.59% above the last closing price of $4.21.
Analysts covering Moolec Science SA currently have a consensus Earnings Per Share (EPS) forecast of -$0.26 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Moolec Science SA. Over the past six months, its share price has underperformed the S&P500 Index by -94.98%.
As of the last closing price of $4.21, shares in Moolec Science SA were trading -91.87% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Moolec Science SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $4.21.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Moolec Science SA's directors